| 2025-11-07 | +29.7% | earnings | Seeking Alpha | 10x Genomics signals 5% sequential revenue growth for Q4 2025 as new product launches drive adoption |
| 2025-11-07 | +29.7% | earnings | Seeking Alpha | 10x Genomics, Inc. (TXG) Q3 2025 Earnings Call Transcript |
| 2025-11-07 | +29.7% | news | Yahoo Finance | Why 10x Genomics (TXG) Stock Is Trading Up Today - Yahoo Finance |
| 2022-07-14 | -25.1% | legal | SEC EDGAR | TXG 8-K: 2.02, 8.01 (SEC Filing) |
| 2021-05-05 | -22.7% | legal | SEC EDGAR | TXG 8-K: 2.02 and (SEC Filing) |
| 2024-10-09 | -22.6% | legal | SEC EDGAR | TXG 8-K: 2.02 and (SEC Filing) |
| 2022-11-02 | +16.6% | legal | SEC EDGAR | TXG 8-K: 2.02 and (SEC Filing) |
| 2023-02-15 | +15.9% | legal | SEC EDGAR | TXG 8-K: 2.02 and (SEC Filing) |
| 2025-11-06 | +14.0% | earnings | Seeking Alpha | 10x Genomics GAAP EPS of -$0.22 beats by $0.08, revenue of $149M beats by $6.48M |
| 2025-11-06 | +14.0% | legal | SEC EDGAR | TXG 8-K: 2.02 and (SEC Filing) |
| 2025-11-06 | +14.0% | news | PR Newswire | 10x Genomics Reports Third Quarter 2025 Financial Results - PR Newswire |
| 2025-11-06 | +14.0% | earnings | Yahoo Finance | 10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance |
| 2025-11-06 | +14.0% | earnings | StockStory | 10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% - StockStory |
| 2022-02-16 | -13.0% | legal | SEC EDGAR | TXG 8-K: 2.02 and (SEC Filing) |
| 2023-11-02 | +12.9% | legal | SEC EDGAR | TXG 8-K: 2.02 and (SEC Filing) |
| 2026-03-13 | -12.3% | news | Investing.com | Cathie Wood’s ARK stock trades highlight CRISPR buys, 10x Genomics sells - Investing.com |
| 2021-11-03 | +11.6% | legal | SEC EDGAR | TXG 8-K: 2.02 and (SEC Filing) |
| 2024-07-11 | +11.6% | legal | SEC EDGAR | TXG 8-K: 5.02 (SEC Filing) |
| 2026-01-02 | +11.5% | news | Yahoo Finance | 10x Genomics (TXG) Stock Is Up, What You Need To Know - Yahoo Finance |
| 2026-01-02 | +11.5% | news | StockStory | 10x Genomics (TXG) Stock Is Up, What You Need To Know - StockStory |
| 2026-01-20 | +11.4% | news | Investing.com | 10X Genomics stock hits 52-week high of 21.52 USD - Investing.com |
| 2026-04-20 | -11.1% | expansion | Zacks | 10x Genomics Stock Up on Atera Launch, Spatial Biology Scale Enhanced |
| 2026-04-20 | -11.1% | earnings | Zacks | Here's How Zimmer Biomet Is Placed Ahead of Q1 Earnings |
| 2026-04-20 | -11.1% | earnings | MarketBeat | 10x Genomics (NASDAQ:TXG) Reaches New 1-Year High - Here's What Happened - MarketBeat |
| 2026-04-20 | -11.1% | earnings | MarketBeat | 10x Genomics (NASDAQ:TXG) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat |
| 2026-04-20 | -11.1% | earnings | MarketBeat | Bayforest Capital Ltd Has $286,000 Holdings in 10x Genomics $TXG - MarketBeat |
| 2025-12-11 | -11.0% | news | Yahoo Finance | Why 10x Genomics (TXG) Stock Is Nosediving - Yahoo Finance |
| 2025-12-11 | -11.0% | news | TradingView | Why 10x Genomics (TXG) Stock Is Nosediving - TradingView |
| 2025-10-19 | +10.0% | news | Yahoo Finance | 10x Genomics (TXG): Assessing Valuation After Recent Share Price Volatility - Yahoo Finance |
| 2024-08-08 | +9.9% | legal | SEC EDGAR | TXG 8-K: 2.02, 5.02, 8.01 (SEC Filing) |
| 2024-01-16 | -9.9% | legal | SEC EDGAR | TXG 8-K: 5.02 (SEC Filing) |
| 2025-10-20 | +9.1% | news | Seeking Alpha | 10X Genomics to integrate analysis tools into Anthropic's Claude for Life Sciences |
| 2025-10-20 | +9.1% | news | Finviz | Why Is 10x Genomics (TXG) Stock Rocketing Higher Today - Finviz |
| 2025-10-20 | +9.1% | news | Stock Titan | 10x Genomics (NASDAQ: TXG) teams with Anthropic to bring single cell analysis to Claude - Stock Titan |
| 2026-03-24 | +9.0% | news | Seeking Alpha | 10x Genomics: Undervalued Amid Consumables-Led Transition |
| 2026-03-24 | +9.0% | news | Seeking Alpha | 10x Genomics: Undervalued Amid Consumables-Led Transition (NASDAQ:TXG) - Seeking Alpha |
| 2026-03-24 | +9.0% | news | Stock Titan | Vanguard amends 13G for 10X Genomics (NASDAQ: TXG) reporting 0 shares - Stock Titan |
| 2026-01-06 | +8.8% | analyst | Trefis | 10x Genomics Stock (+10%): Analyst Upgrades Spark a Short Cover Rally - Trefis |
| 2026-03-31 | +7.6% | news | Benzinga | 10x Genomics Seen As Key Player In AI-Driven Biological Data Buildout - 10x Genomics (NASDAQ:TXG) - Benzinga |
| 2025-10-15 | +7.5% | news | Yahoo Finance | Why 10x Genomics (TXG) Stock Is Trading Up Today - Yahoo Finance |
| 2026-04-22 | -7.4% | news | Stock Titan | TXG Financials: Income Statement, Balance Sheet & Cash Flow | 10X Genomics, Inc. - Stock Titan |
| 2026-04-22 | -7.4% | earnings | Cổng thông tin điện tử Tỉnh Sơn La | TXG 10x Genomics reports narrower Q4 2025 loss and 5.2 percent annual revenue growth, yet shares drop 5.71 percent today. - Cost Advantage - Cổng thông tin điện tử Tỉnh Sơn La |
| 2023-05-03 | +7.3% | legal | SEC EDGAR | TXG 8-K: 2.02 and (SEC Filing) |
| 2026-02-11 | -7.0% | earnings | Seeking Alpha | 10x Genomics Q4 2025 Earnings Preview |
| 2025-05-09 | +6.8% | earnings | Seeking Alpha | 10x Genomics, Inc. (TXG) Q1 2025 Earnings Call Transcript |
| 2026-01-27 | -6.7% | analyst | Investing.com | Leerink Partners lowers 10X Genomics stock price target on pricing concerns - Investing.com |
| 2025-06-25 | +6.6% | news | Seeking Alpha | Life sciences tools companies higher as NIH pauses cancellation of research grants |
| 2026-02-04 | -6.5% | news | Stock Titan | Latest TXG News - 10x Genomics Introduces Atera, a New Platfor... - Stock Titan |
| 2026-02-04 | -6.5% | news | Stock Titan | UK project turns decades of NHS cancer samples into AI-ready data - Stock Titan |
| 2026-01-13 | +6.3% | news | Seeking Alpha | 10x Genomics, Inc. (TXG) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow |
| 2025-10-21 | -6.2% | legal | Seeking Alpha | Illumina faces patent lawsuits from 10x Genomics over gene sequencing tech |
| 2025-10-21 | -6.2% | news | Yahoo Finance | 10x Genomics (TXG) Moves 11.1% Higher: Will This Strength Last? - Yahoo Finance |
| 2026-02-13 | +6.1% | news | Yahoo Finance | Why Is 10x Genomics (TXG) Stock Soaring Today - Yahoo Finance |
| 2026-02-13 | +6.1% | earnings | Finviz | TXG Q4 Deep Dive: Consumables Growth, Spatial Expansion, and AI-Driven Demand Shape Outlook - Finviz |
| 2022-08-08 | +6.0% | legal | SEC EDGAR | TXG 8-K: 2.02 and (SEC Filing) |
| 2025-08-21 | +5.9% | news | Yahoo Finance | 3 Reasons TXG is Risky and 1 Stock to Buy Instead - Yahoo Finance |
| 2026-04-19 | -5.5% | news | PR Newswire | 10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood |
| 2026-04-19 | -5.5% | news | ChartMill | 10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood - ChartMill |
| 2026-04-19 | -5.5% | news | The Chronicle-Journal | 10x Genomics, Inc. - Common Stock (NQ: TXG - The Chronicle-Journal |
| 2026-04-19 | -5.5% | expansion | Intellectia AI | 10x Genomics Launches Atera Platform for Spatial Biology - Intellectia AI |
| 2026-04-18 | -5.5% | news | PR Newswire | 10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood - PR Newswire |
| 2026-04-18 | -5.5% | news | Investing.com India | 10X Genomics stock hits 52-week high at 26.07 USD By Investing.com - Investing.com India |
| 2026-04-14 | +5.5% | earnings | MarketBeat | 10x Genomics (NASDAQ:TXG) Hits New 12-Month High - What's Next? - MarketBeat |
| 2026-04-14 | +5.5% | earnings | MarketBeat | 10x Genomics $TXG Shares Bought by Sumitomo Mitsui Trust Group Inc. - MarketBeat |
| 2025-05-07 | +5.4% | earnings | Seeking Alpha | 10x Genomics Q1 2025 Earnings Preview |
| 2025-03-13 | -5.4% | news | Seeking Alpha | Stock selloff slashes needed-market cap for new Russell 2000 additions: Stephens |
| 2025-05-14 | -5.3% | legal | Seeking Alpha | Bruker and 10x Genomics reach global settlement of patent litigation |
| 2025-05-14 | -5.3% | legal | SEC EDGAR | TXG 8-K: 8.01 (SEC Filing) |
| 2026-03-05 | -5.1% | executive | Investing.com | 10x genomics CEO Saxonov sells $367,096 in shares - Investing.com |
| 2025-08-29 | -5.0% | news | simplywall.st | Have 10x Genomics Insiders Been Selling Stock? - simplywall.st |
| 2026-03-16 | -5.0% | news | Seeking Alpha | Cathie Wood's weekly recap: adds JOBY, CRSP, TEM, sells TER, TXG, CRCL |
| 2026-03-16 | -5.0% | news | Investing.com | 10x Genomics stock tumbles as ARK Invest dumps shares By Investing.com - Investing.com |
| 2025-05-08 | +5.0% | earnings | Seeking Alpha | 10x Genomics GAAP EPS of -$0.28 beats by $0.19, revenue of $154.9M beats by $22.39M |
| 2025-05-08 | +5.0% | legal | SEC EDGAR | TXG 8-K: 2.02, 2.05 (SEC Filing) |
| 2026-03-20 | +4.8% | news | Yahoo Finance | 3 Reasons to Sell TXG and 1 Stock to Buy Instead - Yahoo Finance |
| 2021-07-27 | +4.6% | legal | SEC EDGAR | TXG 8-K: 1.01, 7.01 (SEC Filing) |
| 2026-03-04 | -4.5% | executive | Stock Titan | 10x Genomics (TXG) CEO sells shares and makes stock gift - Stock Titan |
| 2025-08-08 | -4.4% | news | Yahoo Finance | Why 10x Genomics (TXG) Stock Is Falling Today - Yahoo Finance |
| 2025-08-08 | -4.4% | earnings | Yahoo Finance | 10x Genomics (NASDAQ:TXG) Reports Upbeat Q2, Stock Soars - Yahoo Finance |
| 2025-09-10 | -4.4% | news | Seeking Alpha | 10x Genomics, Inc. (TXG) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript |
| 2026-03-25 | +4.4% | executive | Stock Titan | 10x Genomics (NASDAQ: TXG) CEO sells 15,000 shares under Rule 10b5-1 plan - Stock Titan |
| 2026-03-25 | +4.4% | news | Stock Titan | Vanguard realigns reporting; subsidiaries to report TXG holdings (TXG) - Stock Titan |
| 2026-03-25 | +4.4% | executive | Investing.com | 10x genomics CEO Saxonov sells $288,908 in stock - Investing.com |
| 2026-03-25 | +4.4% | news | Stock Titan | A new atlas aims to map 100,000 patient samples across 3 continents - Stock Titan |
| 2026-04-13 | +4.4% | news | GlobeNewswire | Keys to Succeed in the Booming $300 Million Optical Genome Mapping Market 2026-2030: Bionano Genomics, 10x Genomics, and Oxford Nanopore Technologies Lead |
| 2025-12-01 | -4.4% | analyst | Investing.com | Morgan Stanley assumes coverage on 10X Genomics stock with Equalweight rating - Investing.com |
| 2024-10-29 | +4.1% | legal | SEC EDGAR | TXG 8-K: 2.02, 5.02 (SEC Filing) |
| 2026-02-12 | -3.9% | earnings | Seeking Alpha | 10x Genomics GAAP EPS of -$0.13 beats by $0.08, revenue of $166M beats by $5.65M |
| 2026-02-12 | -3.9% | legal | SEC EDGAR | TXG 8-K: 2.02 and (SEC Filing) |
| 2026-02-12 | -3.9% | news | PR Newswire | 10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026 - PR Newswire |
| 2026-02-12 | -3.9% | earnings | Yahoo Finance | 10x Genomics (TXG) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance |
| 2026-02-12 | -3.9% | news | Stock Titan | 10x Genomics (NASDAQ: TXG) narrows 2025 losses and guides to modest 2026 growth - Stock Titan |
| 2026-02-12 | -3.9% | earnings | TradingView | 10x Genomics (NASDAQ:TXG) Delivers Impressive Q4 CY2025 - TradingView |
| 2023-08-03 | -3.8% | legal | SEC EDGAR | TXG 8-K: 2.02 and (SEC Filing) |
| 2026-04-23 | -3.7% | executive | Business Wire | LiquidCell Dx Appoints Former Foundation Medicine, 10x Genomics and IDT Leader Mirna Jarosz as Chief Executive Officer; Names Former Foundation Medicine Chief Medical Officer Vincent A. Miller, MD, Senior Strategic Advisor |
| 2025-08-07 | -3.6% | M&A | Seeking Alpha | 10x Genomics to acquire Scale Biosciences |
| 2025-08-07 | -3.6% | earnings | Seeking Alpha | 10x Genomics GAAP EPS of $0.28 beats by $0.65, revenue of $172.9M beats by $33.39M |
| 2025-08-07 | -3.6% | legal | SEC EDGAR | TXG 8-K: 2.02 and (SEC Filing) |
| 2026-04-17 | -3.6% | news | StockStory | 3 Overrated Stocks We Keep Off Our Radar |
| 2026-04-17 | -3.6% | news | Investing.com | 10X Genomics stock hits 52-week high at 26.07 USD - Investing.com |
| 2026-02-10 | +3.6% | earnings | StockStory | 10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect - StockStory |
| 2025-09-16 | -3.4% | earnings | Seeking Alpha | 10x Genomics: Surprise Profitability May Be Temporary, But It's Still A Welcome Sign |
| 2025-09-16 | -3.4% | earnings | Seeking Alpha | 10x Genomics: Surprise Profitability May Be Temporary, But It's Still A Welcome Sign - Seeking Alpha |
| 2026-01-10 | -3.4% | earnings | Quiver Quantitative | 10X GENOMICS Q4 2025 Earnings Preview: Recent $TXG Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative |
| 2024-04-30 | -3.3% | legal | SEC EDGAR | TXG 8-K: 2.02 and (SEC Filing) |
| 2023-05-17 | +3.2% | legal | SEC EDGAR | TXG 8-K: 8.01 and (SEC Filing) |
| 2025-11-14 | -3.0% | legal | SEC EDGAR | TXG 8-K: 5.02 (SEC Filing) |
| 2025-08-13 | +3.0% | news | Investing.com | 10X Genomics’ SWOT analysis: genomics firm’s stock faces funding headwinds - Investing.com |
| 2024-01-08 | -3.0% | legal | SEC EDGAR | TXG 8-K: 2.02 and (SEC Filing) |
| 2026-03-06 | -2.9% | earnings | Yahoo Finance | Life Sciences Tools & Services Stocks Q4 In Review: 10x Genomics (NASDAQ:TXG) Vs Peers - Yahoo Finance |
| 2026-02-15 | +2.6% | analyst | StocksToTrade | 10x Genomics Stock Climbs as Analysts Signal Growth Prospects - StocksToTrade |
| 2026-02-14 | +2.6% | earnings | Seeking Alpha | 10x Genomics, Inc. (TXG) Q4 2025 Earnings Call Transcript |
| 2026-02-14 | +2.6% | news | Yahoo Finance | 10x Genomics Cancer Alliances Test AI Ambitions Against Mixed Share Performance - Yahoo Finance |
| 2026-04-07 | +2.6% | earnings | MarketBeat | Citigroup Issues Positive Forecast for 10x Genomics (NASDAQ:TXG) Stock Price - MarketBeat |
| 2026-04-07 | +2.6% | analyst | GuruFocus | Citigroup Maintains Neutral Rating for TXG, Raises Price Target by 33% | TXG Stock News - GuruFocus |
| 2025-11-11 | -2.6% | earnings | Yahoo Finance | 10x Genomics (TXG) Soars to New Record High on Lower Net Loss, Revenue Beat - Yahoo Finance |
| 2025-11-11 | -2.6% | news | TradingView | Why 10x Genomics (TXG) Stock Is Trading Up Today - TradingView |
| 2025-11-11 | -2.6% | news | Stock Titan | 10x Genomics (Nasdaq: TXG) to join Wolfe Research Healthcare Conference at 11:20 a.m. ET - Stock Titan |
| 2025-11-11 | -2.6% | news | FinancialContent | About Us - FinancialContent |
| 2026-04-05 | -2.4% | analyst | Yahoo Finance | Why 10x Genomics (TXG) Is Up 14.6% After Analyst Upgrade And New AI Data Initiative - Yahoo Finance |
| 2026-03-09 | -2.4% | news | Investing.com | Cathie Wood’s ARK trims 10X Genomics stock, adds DraftKings - Investing.com |
| 2026-04-08 | +2.3% | news | Investing.com | 10x Genomics stock hits 52-week high at 23.6 USD - Investing.com |
| 2026-04-08 | +2.3% | earnings | MarketBeat | 10x Genomics (NASDAQ:TXG) Hits New 52-Week High on Analyst Upgrade - MarketBeat |
| 2021-08-04 | -2.0% | legal | SEC EDGAR | TXG 8-K: 2.02 and (SEC Filing) |
| 2026-01-22 | -1.9% | news | Stock Titan | 10x Genomics sets date for 2025 results, investor call and webcast - Stock Titan |
| 2026-01-09 | +1.8% | news | Investing.com | 10X Genomics stock hits 52-week high at 20.36 USD - Investing.com |
| 2025-09-12 | +1.7% | news | Yahoo Finance | 10x Genomics (TXG) Stock Trades Down, Here Is Why - Yahoo Finance |
| 2025-12-22 | +1.7% | news | Yahoo Finance | 10x Genomics (TXG) Stock Trades Up, Here Is Why - Yahoo Finance |
| 2021-06-02 | -1.6% | legal | SEC EDGAR | TXG 8-K: 8.01 and (SEC Filing) |
| 2025-02-13 | +1.6% | earnings | Seeking Alpha | 10x Genomics falls on quarterly EPS miss, 2025 revenue guidance concern |
| 2025-03-20 | +1.5% | news | Seeking Alpha | 10x Genomics: Lower Cost Innovation May Drive A Rebound |
| 2026-04-16 | +1.4% | executive | Stock Titan | 10x Genomics (NASDAQ: TXG) CEO sells 5,000 shares in 10b5-1 trade - Stock Titan |
| 2025-12-07 | -1.4% | earnings | TradingView | Life Sciences Tools & Services Stocks Q3 Earnings: 10x Genomics (NASDAQ:TXG) Firing on All Cylinders - TradingView |
| 2025-06-23 | -1.4% | news | Seeking Alpha | 10x Genomics: Stuck In Neutral |
| 2025-03-03 | +1.3% | news | Seeking Alpha | 10x Genomics gets injunction against Parse Biosciences' ATAC Products |
| 2021-06-15 | +1.3% | legal | SEC EDGAR | TXG 8-K: 1.01, 5.07 (SEC Filing) |
| 2025-01-13 | -1.2% | legal | SEC EDGAR | TXG 8-K: 2.02 and (SEC Filing) |
| 2025-11-03 | -1.1% | news | Seeking Alpha | Cathie Wood's Ark Invest weekly moves: Adds to NTLA and XYZ, trims positions in SOFI and SHOP |
| 2026-04-15 | +0.7% | news | PR Newswire | 10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026 |
| 2026-04-15 | +0.7% | earnings | Stock Titan | After the bell: 10x Genomics posts quarterly results May 7 - Stock Titan |
| 2026-04-15 | +0.7% | earnings | MarketBeat | 10x Genomics $TXG Stake Boosted by Tudor Investment Corp ET AL - MarketBeat |
| 2026-04-15 | +0.7% | legal | Cổng thông tin điện tử tỉnh Tây Ninh | 10x Genomics (TXG) Stock Regulatory Filing (Investor Interest) 2026-04-15 - Retail Money Flow - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2025-12-29 | -0.7% | news | Seeking Alpha | 10x Genomics' Products Are Well-Received, But US Spending Weakness Stifles Growth |
| 2025-12-29 | -0.7% | news | Seeking Alpha | 10x Genomics' Products Are Well-Received, But US Spending Weakness Stifles Growth (NASDAQ:TXG) - Seeking Alpha |
| 2025-11-04 | -0.7% | earnings | Yahoo Finance | 10x Genomics Earnings: What To Look For From TXG - Yahoo Finance |
| 2025-11-04 | -0.7% | earnings | FinancialContent | 10x Genomics Earnings: What To Look For From TXG - FinancialContent |
| 2024-02-15 | +0.6% | legal | SEC EDGAR | TXG 8-K: 2.02 and (SEC Filing) |
| 2026-04-09 | +0.6% | earnings | TMX Newsfile | Torex Gold Reports Q1 2026 Production Results |
| 2025-10-16 | -0.4% | analyst | Yahoo Finance | 10x Genomics (TXG) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance |
| 2023-07-20 | +0.4% | legal | SEC EDGAR | TXG 8-K: 5.02 (SEC Filing) |
| 2025-08-09 | +0.4% | earnings | Seeking Alpha | 10x Genomics, Inc. (TXG) Q2 2025 Earnings Call Transcript |
| 2026-04-12 | +0.4% | news | The Motley Fool | Best Genetic Sequencing Stocks for 2026 and How to Invest in Them - The Motley Fool |
| 2026-01-12 | +0.3% | news | Seeking Alpha | 10x Genomics, Inc. (TXG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript |
| 2026-01-12 | +0.3% | earnings | Seeking Alpha | 10x Genomics sees uptick in Q4 revenue despite softer FY sales |
| 2026-01-12 | +0.3% | legal | SEC EDGAR | TXG 8-K: 2.02 (SEC Filing) |
| 2026-01-12 | +0.3% | news | Yahoo Finance | Why 10x Genomics (TXG) Shares Are Falling Today - Yahoo Finance |
| 2026-01-12 | +0.3% | news | TradingView | Why 10x Genomics (TXG) Shares Are Falling Today - TradingView |
| 2026-01-12 | +0.3% | earnings | Seeking Alpha | 10x Genomics sees uptick in Q4 revenue despite softer FY sales (TXG:NASDAQ) - Seeking Alpha |
| 2026-01-12 | +0.3% | news | Stock Titan | New AI cancer project will map 500 million immune cells for research - Stock Titan |
| 2026-01-12 | +0.3% | news | Stock Titan | New study tracks blood signals to guide care for autoimmune disease patients - Stock Titan |
| 2026-01-12 | +0.3% | news | Stock Titan | New tumor mapping study probes why patients respond differently to treatment - Stock Titan |
| 2026-01-12 | +0.3% | news | Seeking Alpha | 10x Genomics, Inc. (TXG) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow - Seeking Alpha |
| 2025-02-12 | +0.3% | legal | SEC EDGAR | TXG 8-K: 2.02 and (SEC Filing) |
| 2025-11-15 | -0.3% | expansion | Yahoo Finance | 10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch - Yahoo Finance |
| 2026-01-07 | +0.2% | news | Stock Titan | New research map aims to explain why some organ transplants fail - Stock Titan |
| 2025-11-18 | +0.1% | news | StockStory | 3 Reasons to Avoid TXG and 1 Stock to Buy Instead - StockStory |
| 2022-05-04 | +0.1% | legal | SEC EDGAR | TXG 8-K: 2.02 and (SEC Filing) |
| 2024-06-20 | +0.1% | legal | SEC EDGAR | TXG 8-K: 5.02 (SEC Filing) |
| 2026-01-24 | +0.0% | news | simplywall.st | 10x Genomics, Inc. (NASDAQ:TXG) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected - simplywall.st |
| 2026-04-25 | — | news | StockStory | 1 Cash-Heavy Stock to Target This Week and 2 We Ignore |
| 2026-04-24 | — | news | StockStory | Why 10x Genomics (TXG) Shares Are Trading Lower Today |
| 2026-04-24 | — | news | Yahoo Finance | Why 10x Genomics (TXG) Shares Are Trading Lower Today - Yahoo Finance |
| 2026-04-24 | — | news | Stock Titan | 10x Genomics (TXG) details 2026 virtual meeting, director votes and Say on Pay - Stock Titan |
| 2026-04-24 | — | news | simplywall.st | Is 10x Genomics (TXG) Price Reflecting Its Mixed Valuation Signals After Strong 1-Year Run - simplywall.st |
| 2026-04-24 | — | earnings | MarketBeat | 10x Genomics $TXG Shares Acquired by Caprock Group LLC - MarketBeat |